Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page shows Revision: v3.6.3 instead of the previous v3.6.0. This indicates a minor platform update rather than changes to the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status is updated to No longer looking for participants, indicating that the study is no longer seeking participants. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading (previously Intervention / Treatment).SummaryDifference0.4%

- Check25 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor software release rather than a content change.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now shows the latest revision as v3.5.4, replacing the previous v3.5.3 in the revision history.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a website release update rather than any change to the clinical trial study details.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.